TGFB1 and cancer: Cancer cell lines were exposed continuously to 0.1, 1.0, 10, and 100 μM galunisertib in presence or absence of TGF-β (5 ng/mL) and assessed for inhibition of cellular proliferation after 72- and 96-hour incubations using the MTT assay.